Health NVCN FINAL DEADLINE: ROSEN, A LEADING LAW FIRM, Encourages Neovasc Inc. Investors with Losses over $100K to Seek Counsel Before Important January 5 Deadline in Securities Class Action- NVCN December 31, 2020
Health SHAREHOLDER ALERT: WeissLaw LLP Reminds HLIX, XLNX, SNSS, and AKER Shareholders About Its Ongoing Investigations December 30, 2020
Health FINAL DEADLINE APPROACHING: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Neovasc Inc. and Encourages Investors with Losses in Excess of $500,000 to Contact the Firm December 30, 2020
Health HTG Expands Patent Portfolio with New Canadian Patent for its Nuclease Protection Methods for Detection of Nucleotide Variants December 30, 2020
Health Bionano Genomics Granted 180-Day Extension by Nasdaq to Regain Compliance with Bid Price Rule December 30, 2020
Health iCAD Announces Renowned Neuro-Oncologist Santosh Kesari, MD, PhD to Lead Post-Market Study for Treatment of Recurrent Glioblastoma (GBM) with FDA-cleared Xoft Brain IORT Technology to Support Clinical Adoption December 29, 2020